Company profile
OncoSec Medical Incorporated
OTC: ONCSQ · Healthcare · Biotechnology
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 12GM —SS 39
v0.1 · 25/100 weight · pillars only
↑ listing tenure, workforce scale · ↓ disclosure history, market scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$34.2M
Employees
40
as of 2026-08-30
Market cap
$596
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02013
Net income-$34.2M-$34.2M2022
Operating income-$37.0M-$37.0M2022
Total assets$21.9M$21.9M2022
Liabilities$15.8M$15.8M2022
Equity$6.1M$6.1M2022
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is OncoSec Medical Incorporated’s revenue?
OncoSec Medical Incorporated booked $0 in FY2013 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
BioELife Corp.——Rapid Therapeutic Science Laboratories, Inc.——North Bud Farms Inc.——Cannabiz Mobile, Inc.——Verde Science, Inc.——Lexington Biosciences, Inc.——Neighbors
Mercer →Key facts
CEO—
SectorHealthcare
IndustryBiotechnology
HeadquartersPennington, NJ
ExchangeOTC: ONCSQ
Employees40
IPO date2010-04-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.